Ideal Power Inc is a technology company specializing in renewable energy solutions, particularly focusing on the development of advanced power conversion technologies
The company aims to enhance the efficiency and performance of electric power systems, including energy storage and distribution applications, which are critical for integrating renewable energy sources into the grid. Through its innovative power electronics technology, Ideal Power seeks to enable a more sustainable energy landscape by facilitating the adoption of clean energy solutions and improving the reliability of energy systems.
Ideal Power Inc announced a joint development agreement for an SSCB product with a leading Asian circuit protection equipment manufacturer targeting completion in 2nd quarter of 2025 and potential for million dollars in revenue.
Ideal Power Inc (NASDAQIPWR) partners with Sekorm Advanced Technology to distribute its products in China, the world's largest market for power semiconductors.
RYOSHO to distribute Ideal Power's products globally. Orders already placed by a large global customer. Ideal Power utilizes asset-light business model.
Ideal Power Inc (NASDAQIPWR) reported first-quarter FY24 commercial revenue of $78,739, a notable increase from zero last year. Operating expenses fell to $2.5 million from $2.6 million. The company completed a public offering, raising $15.7 million, and held $20.2 million in cash by March 31, 2024, with no outstanding long-term debt. Ideal Power expects its SymCool power module to drive early sales in industrial markets.
Ideal Power Inc (NASDAQIPWR) partners with Richardson Electronics to distribute its products globally, including B-TRAN device and SymCool power module.
Ideal Power completed Phase II of a partnership with Stellantis to develop a B-TRAN power module for use in electric vehicles, with potential for wider adoption in the automotive industry.
Ideal Power Inc (NASDAQIPWR) announced commercial shipment of its highly efficient SymCool Power Module, targeting various applications. CEO expects conversions and custom deals in 2021.
Shares of Lantheus Holdings, Inc. (NASDAQLNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
